Enstilar® Calcipotriene/Betamethasone Dipropionate 0.005%-0.064% Foam for Plaque Psoriasis Treatment
USAMP#65147620SKU: 50222030266Enstilar®
License Required



Product Spotlight
- Enstilar® Foam combines calcipotriene and betamethasone dipropionate to effectively treat plaque psoriasis in adults over 18.
- Specifically formulated for topical use, Enstilar® Foam is a leading prescription treatment for managing symptoms of plaque psoriasis on the skin.
- Users are advised to avoid applying Enstilar® Foam on the face, groin, underarms, or areas with skin thinning (atrophy).
- It is important to prevent contact with eyes, mouth, or vagina to avoid irritation.
- Each carton provides two 60g cans, ensuring a comprehensive treatment course.